Pages that link to "Q41521915"
Jump to navigation
Jump to search
The following pages link to The hyperparathyroidism of chronic renal failure: A disorder of growth (Q41521915):
Displaying 50 items.
- Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis (Q28484646) (← links)
- Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis (Q28505228) (← links)
- Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel (Q30460906) (← links)
- Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients (Q30882562) (← links)
- A practical guide to the management of hypertension in renal transplant recipients (Q33826211) (← links)
- Perspective on assessment of vitamin D nutrition (Q33839510) (← links)
- Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease (Q33917786) (← links)
- Management of renal hyperparathyroidism (Q33983813) (← links)
- Cyclooxygenase 2 Promotes Parathyroid Hyperplasia in ESRD (Q34726849) (← links)
- The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease (Q35119028) (← links)
- Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice (Q35119033) (← links)
- Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach (Q35553301) (← links)
- Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials (Q35571939) (← links)
- Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial (Q35658608) (← links)
- How Well Does Renal Transplantation Cure Hyperparathyroidism? (Q36077767) (← links)
- D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management (Q36174291) (← links)
- Influence of parathyroid mass on the regulation of PTH secretion. (Q36523927) (← links)
- EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease (Q36677409) (← links)
- Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis (Q36688447) (← links)
- Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics (Q36849325) (← links)
- Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism (Q36906034) (← links)
- Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism (Q37102086) (← links)
- Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism (Q37123402) (← links)
- A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. (Q37614180) (← links)
- Localized mandibular enlargement in end-stage renal disease: two case reports and a review of the literature (Q38016984) (← links)
- Phosphate overload accelerates vascular aging in uremic patients (Q38605311) (← links)
- Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation (Q39225566) (← links)
- Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet. (Q39427686) (← links)
- Charcot neuroarthropathy after simultaneous pancreas-kidney transplantation: risk factors, prevalence, and outcome (Q41702060) (← links)
- Mediastinal hemorrhage due to ectopic parathyroid hyperplasia with long-term hemodialysis: report of a case (Q41956783) (← links)
- Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients. (Q42685461) (← links)
- Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism (Q42939543) (← links)
- Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation (Q44185820) (← links)
- Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study. (Q44993064) (← links)
- Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease (Q46574367) (← links)
- Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency (Q46709389) (← links)
- Interleukin-6, transforming growth factor-beta 1, and bone markers after kidney transplantation (Q47901661) (← links)
- Are parathyroidectomies still appropriate in chronic dialysis patients? (Q50106981) (← links)
- Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia. (Q52721559) (← links)
- Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis. (Q53157310) (← links)
- A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. (Q53667768) (← links)
- The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD (Q60921125) (← links)
- No marked apoptosis of parathyroid cells after intraparathyroid injections of Calcijex-observation in a patient with tertiary hyperparathyroidism after successful renal transplantation (Q73487863) (← links)
- Progressive paraparesia of 2 months of evolution in a 24 years-old woman with a renal transplantation (Q74042706) (← links)
- Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure (Q74451565) (← links)
- Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency (Q77298539) (← links)
- Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism (Q77958507) (← links)
- Pathogenic mechanisms for parathyroid hyperplasia (Q79817446) (← links)
- Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients (Q82888079) (← links)
- Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis (Q83887620) (← links)